175 related articles for article (PubMed ID: 11705991)
21. Analysis of global gene expression and double-strand-break formation in DNA adenine methyltransferase- and mismatch repair-deficient Escherichia coli.
Robbins-Manke JL; Zdraveski ZZ; Marinus M; Essigmann JM
J Bacteriol; 2005 Oct; 187(20):7027-37. PubMed ID: 16199573
[TBL] [Abstract][Full Text] [Related]
22. Binding of the Escherichia coli UvrAB proteins to the DNA mono- and diadducts of cis-[N-2-amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II ) and cisplatin. Analysis of the factors controlling recognition and proof of monoadduct-mediated UvrB-DNA cross-linking.
Lambert B; Jestin JL; Bréhin P; Oleykowski C; Yeung AT; Mailliet P; Prétot C; Le Pecq JB; Jacquemin-Sablon A; Chottard JC
J Biol Chem; 1995 Sep; 270(36):21251-7. PubMed ID: 7673159
[TBL] [Abstract][Full Text] [Related]
23. Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.
Rennicke A; Voigt W; Mueller T; Fruehauf A; Schmoll HJ; Beyer C; Dempke W
Anticancer Res; 2005; 25(2A):1147-55. PubMed ID: 15868958
[TBL] [Abstract][Full Text] [Related]
24. Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant.
Calmann MA; Nowosielska A; Marinus MG
Nucleic Acids Res; 2005; 33(4):1193-200. PubMed ID: 15731339
[TBL] [Abstract][Full Text] [Related]
25. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.
Saris CP; van de Vaart PJ; Rietbroek RC; Blommaert FA
Carcinogenesis; 1996 Dec; 17(12):2763-9. PubMed ID: 9006117
[TBL] [Abstract][Full Text] [Related]
26. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin: mechanism of action and antineoplastic activity.
Raymond E; Faivre S; Woynarowski JM; Chaney SG
Semin Oncol; 1998 Apr; 25(2 Suppl 5):4-12. PubMed ID: 9609103
[TBL] [Abstract][Full Text] [Related]
28. Recognition of platinum-DNA adducts by HMGB1a.
Ramachandran S; Temple B; Alexandrova AN; Chaney SG; Dokholyan NV
Biochemistry; 2012 Sep; 51(38):7608-17. PubMed ID: 22950413
[TBL] [Abstract][Full Text] [Related]
29. ATP increases the affinity between MutS ATPase domains. Implications for ATP hydrolysis and conformational changes.
Lamers MH; Georgijevic D; Lebbink JH; Winterwerp HH; Agianian B; de Wind N; Sixma TK
J Biol Chem; 2004 Oct; 279(42):43879-85. PubMed ID: 15297450
[TBL] [Abstract][Full Text] [Related]
30. Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).
Sedletska Y; Fourrier L; Malinge JM
J Mol Biol; 2007 May; 369(1):27-40. PubMed ID: 17400248
[TBL] [Abstract][Full Text] [Related]
31. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
32. Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.
Wu Y; Bhattacharyya D; King CL; Baskerville-Abraham I; Huh SH; Boysen G; Swenberg JA; Temple B; Campbell SL; Chaney SG
Biochemistry; 2007 Jun; 46(22):6477-87. PubMed ID: 17497831
[TBL] [Abstract][Full Text] [Related]
33. The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Perego P; Gatti L; Caserini C; Supino R; Colangelo D; Leone R; Spinelli S; Farrell N; Zunino F
J Inorg Biochem; 1999 Oct; 77(1-2):59-64. PubMed ID: 10626355
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
[TBL] [Abstract][Full Text] [Related]
35. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
36. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
37. Crystal structure and biochemical analysis of the MutS.ADP.beryllium fluoride complex suggests a conserved mechanism for ATP interactions in mismatch repair.
Alani E; Lee JY; Schofield MJ; Kijas AW; Hsieh P; Yang W
J Biol Chem; 2003 May; 278(18):16088-94. PubMed ID: 12582174
[TBL] [Abstract][Full Text] [Related]
38. [High expression and identification of DNA mismatch repair gene mutS in Escherichia coli].
Bi LJ; Zhou YF; Deng JY; Zhang XE; Zhang CG; Cass AE
Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):536-40. PubMed ID: 12561194
[TBL] [Abstract][Full Text] [Related]
39. Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA.
Woynarowski JM; Chapman WG; Napier C; Herzig MC; Juniewicz P
Mol Pharmacol; 1998 Nov; 54(5):770-7. PubMed ID: 9804612
[TBL] [Abstract][Full Text] [Related]
40. The coordinated functions of the E. coli MutS and MutL proteins in mismatch repair.
Acharya S; Foster PL; Brooks P; Fishel R
Mol Cell; 2003 Jul; 12(1):233-46. PubMed ID: 12887908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
